Study at ENDO 2026 Highlights Start and Stop Patterns in GLP-1 Adherence Among Patients with Type 2 Diabetes
The clinical landscape for managing type 2 diabetes and obesity has been fundamentally altered by the advent of glucagon-like peptide-1…
The clinical landscape for managing type 2 diabetes and obesity has been fundamentally altered by the advent of glucagon-like peptide-1…
The landscape of endocrinology research is undergoing a transformative shift as the demand for higher sensitivity, greater throughput, and uncompromising…
A groundbreaking study published in the journal Endocrinology has shed new light on the critical windows of thyroid hormone influence…
On July 15, a landmark coalition of 38 professional medical organizations, patient advocacy groups, and research institutions formally endorsed the…
The Centers for Medicare & Medicaid Services (CMS) officially released the Calendar Year (CY) 2027 Medicare Physician Fee Schedule (MPFS)…
The Clinical Intersection of Cushing’s Syndrome and Metabolic Disease Endogenous Cushing’s syndrome is a rare but devastating endocrine disorder characterized…
The global healthcare landscape is currently grappling with a dual epidemic: a surge in type 2 diabetes and a rising…
Following the conclusion of the ENDO 2026 annual meeting in Chicago, the Endocrine Society has officially pivoted its focus toward…
The healthcare landscape is currently witnessing a paradigm shift where artificial intelligence (AI) is transitioning from a high-tech novelty to…
The medical landscape for patients diagnosed with acromegaly has undergone a radical transformation over the last several decades, according to…